Task Force issues recommendations on cervical cancer screening and screening for diabetes in adults and pregnant women

2003 ◽  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Pregnant Women ◽  
Cervical Cancer Screening ◽  
Task Force

Impact of the Current US Preventive Services Task Force Recommendations for Cervical Cancer Screening in Young Women 21 to 29 Years Old

2020 ◽  
Vol 153 (6) ◽  
pp. 734-742 ◽  
Author(s):  
C Paul Morris ◽  
Sayanan Chowsilpa ◽  
Sara Mustafa ◽  
Isaac Chan ◽  
Daniel Miller ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Task Force ◽  
Statistical Significance ◽  
Academic Medical Center ◽  
Tertiary Care ◽  
Preventive Services ◽  
High Grade ◽  
The Impact

Abstract Objectives In 2012, the US Preventive Services Task Force decreased the recommended frequency of cervical cytology screening to once every 3 years and recommended against testing women younger than 21 years regardless of sexual history. We evaluated the impact of this in 21 to 29-year-old women at a tertiary care academic medical center in 2011 and 2017. Methods We retrospectively analyzed Papanicolaou test results at two time points in 21- to 29-year-old women. Results There was a decrease in the number of high-grade lesions in 21- to 25-year-old women (odds ratio [OR], 0.36) from 2011 to 2017. Within the 26- to 29-year-old patient group, there was a trend toward a higher percentage of high-grade squamous intraepithelial lesion (HSIL) in 2017 compared to 2011 on cytology, which did not reach statistical significance (OR, 1.46). However, follow-up histologic specimens showed a higher percentage of HSIL in 2017 compared to 2011 in this age group (OR, 2.16). Conclusions Our findings suggest that the cervical cancer screening guidelines introduced in 2012 have not had a detrimental impact on the outcomes of cervical cancer screening for 21- to 25-year-old women. However, we need to continue monitoring the effects of decreased screening in 26- to 29-year-old women.

scholarly journals Postpartum Pap Smear Results in Women with Abnormal Pap Smears Detected at First Antenatal Care: A Retrospective Study in a Songklanagarind Hospital

2021 ◽  
Vol 1 (2) ◽  
pp. 55-62
Author(s):  
Nungrutai Saeaib
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Antenatal Care ◽  
Pregnant Women ◽  
Cervical Cancer Screening ◽  
Pap Smear ◽  
Remission Rate ◽  
Pap Smears ◽  
Care Providers ◽  
Pregnancy And Postpartum

Objective: To assess the remission rate at postpartum periods of abnormal Pap smears during pregnancy, and to identify the demographic and clinical characteristics of pregnant women with abnormal Pap smears.Material and Methods: Pregnant women, who had antenatal care (ANC) in Songklanagarind Hospital in period of January 2011 to December 2019, were identified retrospectively. Exclusion criteria included inaccessible results of Pap smears during pregnancy and postpartum periods. Medical records of all pregnant women with abnormal Pap smears were reviewed. The association between Pap smear results during pregnancy and postpartum were analyzed by Cramer’s V statistic ranging from 0 to 1, with a 1 indicating perfect association.Results: Of these 8,238 pregnant women had available Pap smear results, 109 (1.3%) women were shown with abnormal results. The most common of abnormality from Pap smears were atypical squamous cells of undetermined significance. In postpartum period, 50 women who had abnormal Pap smear during pregnancy, underwent postpartum follow-up examination at six weeks postpartum, respectively. The majority of results (84.0%) were normal whilst rate of remission occurred in 45 women (90.0%). The association of Pap smears between during pregnancy and postpartum was shown to have a small association (Cramer’s V = 0.2).Conclusion: There was low prevalence of abnormal Pap smear during pregnancy and high remission rate at postpartum. However, health care providers should be aware of cervical cancer screening in all pregnant women, because many women had not undergone cervical cancer screening before pregnancy.

scholarly journals State of the Science: Screening, Surveillance, and Epidemiology of HPV-Related Malignancies

2021 ◽  
pp. 1-12
Author(s):  
Rahel Ghebre ◽  
J. Michael Berry-Lawhorn ◽  
Gypsyamber D’Souza
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
High Resolution ◽  
Cervical Cancer Screening ◽  
Task Force ◽  
Hpv Vaccination ◽  
Cancer Society ◽  
Screening Guidelines ◽  
Cancer Precursors ◽  
The U.S

Oropharyngeal, cervical, vulvar, and anal cancers share a common risk factor of HPV infection. HPV vaccination is currently recommended at age 11 or 12 to prevent new HPV infections for all genders with catch-up vaccination recommened up to age 26. Despite the known effectiveness of HPV vaccination to prevent HPV-related cancer, there is continued low uptake in the United States; only 40% of eligible persons were vaccinated in 2018, though rates are 70% among teenagers. Current American Cancer Society cancer screening guidelines recommend cervical cancer screening, but do not have specific recommendations for screening for other HPV-related cancers. Oropharyngeal cancer precursors have yet to be identified, and there are currently no routine screening tests for oropharyngeal cancer recommended by the U.S. Preventive Services Task Force. The U.S. Preventive Services Task Force and American Cancer Society recommend cervical cancer screening for women at average risk up to age 65, and screening guidelines do not currently differ by HPV vaccination status. Primary HPV DNA testing was first approved for cervical cancer screening in 2016 and was shown to be superior for cervical cancer prevention. Vulvar and anal cancer precursors have been identified, but optimal screening remains unclear. Examination of the anal canal and perianus is best performed by trained clinicians using high-resolution anoscopy, and effectiveness of using high-resolution anoscopy to detect and treat anal high-grade squamous intraepithelial lesions to prevent cancer is actively being researched. Current multistep approaches to control HPV-related malignancies include HPV vaccination coupled with cervical cancer screening or surveillance for oropharyngeal, vulvar, and anal cancers.

An assessment of the United States Preventive Services Task Force cervical cancer screening guidelines

2021 ◽  
Vol 162 ◽  
pp. S88
Author(s):  
Vaidehi Mujumdar ◽  
Alexander Martin ◽  
Sushmita Gordhandas ◽  
Nita Lee
Keyword(s):  
United States ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Task Force ◽  
Preventive Services ◽  
The United States ◽  
Screening Guidelines

Safety and usefulness of the Cervex brush® for uterine cervical cancer screening of pregnant women

2018 ◽  
Vol 57 (1) ◽  
pp. 7-12 ◽  
Author(s):  
Shinichi ISHIOKA ◽  
Miseon KIM ◽  
Seiro SATOHISA ◽  
Mizue TERAMOTO ◽  
Ryoichi TANAKA ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Pregnant Women ◽  
Cervical Cancer Screening ◽  
Uterine Cervical Cancer

scholarly journals Adherence to US Preventive Services Task Force recommendations for breast and cervical cancer screening for women who have a spinal cord injury

2016 ◽  
Vol 40 (1) ◽  
pp. 76-84 ◽  
Author(s):  
Xinling Xu ◽  
Joshua R. Mann ◽  
James W. Hardin ◽  
Erin Gustafson ◽  
Suzanne W. McDermott ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Task Force ◽  
Preventive Services ◽  
Breast And Cervical Cancer ◽  
Cord Injury

scholarly journals Cervical Cytologic Examination During Physical Checkup of Pregnant Women: Cervical Cancer Screening in Women Under the Age of Thirty

2004 ◽  
Vol 204 (3) ◽  
pp. 221-228 ◽  
Author(s):  
Yoriko Abe ◽  
Kiyoshi Ito ◽  
Chikako Okamura ◽  
Hitoshi Niikura ◽  
Yukihiro Terada ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Pregnant Women ◽  
Cervical Cancer Screening ◽  
Cytologic Examination

scholarly journals Age and Cervical Cancer Screening Recommendations

2021 ◽  
Vol 9 (4) ◽  
Author(s):  
Elliot Levine ◽  
Norman Ginsberg ◽  
Carlos Fernandez
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Task Force ◽  
Current Data ◽  
Cancer Society ◽  
Age Related ◽  
The Us ◽  
American Society ◽  
Preventative Services

Recommendations for cervical cancer screening have had remarkable agreement from a number of medical societies, including the American College of Obstetricians and Gynecologists (ACOG), American Cancer Society (ACS), American Society of Cervical Colposcopy and Pathology (ASCCP), and the US Preventative Services Task Force (USPSTF). Reference to the recommended age for screening may need to be re-examined, in light of current data regarding the comparative age-related incidence of cervical malignancy, especially when recognizing the past utility of screening with exfoliative cytology in reducing subsequent mortality.

Impacts of Canadian Task Force on Preventive Health (Ctfph) Guidelines “Cytology” Versus American Society Clinical Oncology (ASCO) HPV Guidelines “HPV” for Cervical Cancer Screening

2018 ◽  
Vol 40 (6) ◽  
pp. 849-850
Author(s):  
Catherine Popadiuk ◽  
Cindy Gauvreau ◽  
Natalie Fitzgerald ◽  
Saima Memon ◽  
Claude Nadeau ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Clinical Oncology ◽  
Task Force ◽  
Preventive Health ◽  
American Society

scholarly journals Evaluation of papsmear in pregnancy

2021 ◽  
Vol 10 (6) ◽  
pp. 2374
Author(s):  
Samar Rudra ◽  
Ajita Mishra ◽  
Akanksha Verma
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Pregnant Women ◽  
Cervical Cancer Screening ◽  
Pap Smear ◽  
Screening Method ◽  
Health Care Facilities ◽  
Cervical Cytology ◽  
Screening Methods ◽  
Care Clinic

Background: Cervical cancer is common worldwide and ranks fourth among all malignancies for women. Cervical cytology (PAP smear) as a cancer screening method is most commonly used worldwide. Cervical cancer can be detected at an early stage by PAP smear which is a cost effective and easy to perform test which is also very safe in pregnant women, hence this study is taken up as an opportunistic time for cervical cancer screening to this accessible group of women during their antenatal period and to find detection rate of infectious diseases, precancerous and cancerous pathology of the cervix.Methods: 500 pregnant women of age 21 years and above and between 16-24 weeks of gestation attending the antenatal OPD were included in the study. Scrapings were obtained from the ectocervix and sent for cytological evaluation. Findings were tabulated and statistically analysed.Results: 7.2% of the patients in our study had cervical infection which included candidiasis and trichomonial infections. 0.4% of the patients had abnormal PAP report, and 88.2% had inflammatory smear implying higher risk of STD’s and pregnancy related complications.Conclusions: The cervical cytology is highly recommended for the routine screening in the antenatal care clinic specially for women who had no prior cervical cancer screening. Awareness on cervical cancer, preventive measures and screening methods need to be strengthened among pregnant women when they visit health care facilities and also in the community settings.

Sign in / Sign up

Export Citation Format

Share Document